Reviews on Recent Clinical Trials


Ludovico Abenavoli
University Magna Graecia


Become EABM
Become Reviewer

Editorial [Hot Topic: Novel Kinase Inhibitors in Cancer Therapy (Guest Editors: Ezra E.W. Cohen and Nikolai G. Rainov)] promotion: free to download

Volume:2   Issue: 2
Pp: 85-86
Nikolai G. Rainov and Ezra E. W. Cohen
DOI: 10.2174/157488707780599339

Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma

Volume:2   Issue: 2
Pp: 87-101
H. Ren, B. F. Yang and Nikolai G. Rainov
DOI: 10.2174/157488707780599384

Therapeutic Strategies for Targeting BRAF in Human Cancer

Volume:2   Issue: 2
Pp: 121-134
Christine A. Pratilas and David B. Solit
DOI: 10.2174/157488707780599393

Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia

Volume:2   Issue: 2
Pp: 135-141
Ryan J. Mattison, Kelly R. Ostler, Frederick L. Locke and Lucy A. Godley
DOI: 10.2174/157488707780599320

Review of Clinic Trials: Agents Targeting c-Met

Volume:2   Issue: 2
Pp: 143-147
Oyewale Abidoye, Nadh Murukurthy and Ravi Salgia
DOI: 10.2174/157488707780599357